Evaluation of an Online Platform for Cancer Patient Self-reporting of Chemotherapy Toxicities

Journal of the American Medical Informatics Association

Volumn 14, Issue 3, 2007, Pages 264-268

  Basch, Ethan ^a   Artz, David ^a   Iasonos, Alexia ^a   Speakman, John ^a   Shannon, Kevin ^a   Lin, Kai ^a   Pun, Charmaine ^a   Yong, Henry ^a   Fearn, Paul ^a   Barz, Allison ^a   Scher, Howard I ^a   McCabe, Mary ^a   Schrag, Deborah ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALERTNESS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; DRUG DOSE REGIMEN; E-MAIL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; INTERNET; ONLINE SYSTEM; PATIENT ATTITUDE; PATIENT CARE; PATIENT SATISFACTION; PHYSICIAN; SELF REPORT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTINEOPLASTIC AGENTS; ELECTRONIC MAIL; FEASIBILITY STUDIES; HUMANS; INTERNET; NEOPLASMS; ONLINE SYSTEMS; PATIENT SATISFACTION; QUESTIONNAIRES; SELF CARE; USER-COMPUTER INTERFACE;

EID: 34247400277     PISSN: 10675027     EISSN: None     Source Type: Journal    
DOI: 10.1197/jamia.M2177     Document Type: Article

References (33)

1. Gwede C.K., Johnson D.J., Daniels S.S., and Trotti A. Assessment of toxicity in cooperative oncology clinical trials: the long and short of it. J Oncol Manag 11 2 (2002) 15-21
2. Velikova G., Booth L., Smith A.B., Brown P.M., Lynch P., Brown J.M., et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22 4 (2004) 714-724
3. Science Panel on Interactive Communication and Health. Wired for Health and Well-Being: the Emergence of Interactive Health Communication (1999), US Department of Health and Human Services, US Government Printing Office, Washington, DC April
4. Robinson T.N., Patrick K., Eng T.R., Gustafson D., and Science Panel on Interactive Communication and Health. An evidence-based approach to interactive health communication: a challenge to medicine in the information age. JAMA 280 14 (1998) 1264-1269
5. Fowler Jr. F.J., Barry M.J., Lu-Yao G., Roman A., Wasson J., and Wennberg J.E. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology 42 6 (1993) 622-629
6. Sloan J.A., Cella D., and Hays R.D. Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 58 12 (2005) 1217-1219
7. Kim J.H., Ferziger R., Kawaloff H.B., Sands D.Z., Safran C., and Slack W.V. A web-based rapid prototyping and clinical conversational system that complements electronic patient record system. Medinfo 10 Pt 1 (2001) 628-632
8. Farzanfar R., Finkelstein J., and Friedman R.H. Testing the usability of two automated home-based patient-management systems. J Med Syst 28 2 (2004) 143-153
9. Acquadro C., Berzon R., Dubois D., Leidy N.K., Marquis P., Revicki D., et al. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6 5 (2003) 522-531
10. Morris L.A., and Miller D.W. The regulation of patient-reported outcome claims: need for a flexible standard. Value Health 5 4 (2002) 372-381
11. U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims (2006) Draft guidance released for comment, February 3
12. Burke L., Patrick D., Scott J., Powers J., Rock E., Monroe S., et al. FDA response to papers toward a final guidance (presentation). FDA Guidance on Patient Reported Outcomes: Discussion, Dissemination, and Operationalization (2006) 2006 February 25; Chantilly, Virginia
13. Willke R.J., Burke L.B., and Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials 25 6 (2004) 535-552
14. Wiklund I. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life. Fundam Clin Pharmacol 18 3 (2004) 351-363
15. Fairclough D.L. Patient reported outcomes as endpoints in medical research. Stat Meth Med Res 13 2 (2004) 115-138
16. Webster K., Cella D., and Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 1 1 (2003) 79
17. Cella D., Peterman A., Hudgens S., Webster K., and Socinski M.A. Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane). Cancer 98 4 (2003) 822-831
18. Le P.P., Kohane I.S., and Weeks J.C. Using a pen-based computer to collect health-related quality of life and utilities information. Proc Annu Symp Comput Appl Med Care (1995) 839-843
19. Mooney K.H., Beck S.L., Friedman R.H., and Farzanfar R. Telephone-linked care for cancer symptom monitoring: a pilot study. Cancer Pract 10 3 (2002) 147-154
20. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v3.0. Available at: https://webapps.ctep.nci.nih.gov/webobjs/ctc/webhelp/Welcome_to_CTCAE.htm#Welcome_to_CTCAE_1.htm. Accessed on December 21, 2005.
21. National Cancer Institute, Cancer Therapy Evaluation Program. NCI Guidelines-Expedited adverse event reporting requirements for NCI investigational agents (2001), National Cancer Institute, Bethesda, MD
22. Basch E.A.D., Dulko D., Scher K., Sabbatini P., Hensley M., Mitra N., Speakman J., McCabe M., and Schrag D. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol 23 15 (2005) 3552-3561
23. Basch E., Iasonos A., McDonough T., Barz A., Culkin A., Kris M.G., et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7 11 (2006) 903-909
24. Fries J.F., Bruce B., and Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol 23 5 Suppl 39 (2005) S53-S57
25. Lai J.S., Dineen K., Reeve B.B., Von Roenn J., Shervin D., McGuire M., et al. An item response theory-based pain item bank can enhance measurement precision. J Pain Symptom Manage 30 3 (2005) 278-288
26. Yost K.J., Sorensen M.V., Hahn E.A., Glendenning G.A., Gnanasakthy A., and Cella D. Using multiple anchor- and distribution-based estimates to evaluate clinically meaningful change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) instrument. Value Health 8 2 (2005) 117-127
27. Lai J.S., Cella D., Dineen K., Bode R., Von Roenn J., Gershon R.C., et al. An item bank was created to improve the measurement of cancer-related fatigue. J Clin Epidemiol 58 2 (2005) 190-197
28. Basch E.M., Thaler H.T., Shi W., Yakren S., and Schrag D. Use of information resources by patients with cancer and their companions. Cancer 100 11 (2004) 2476-2483
29. Culkin A., Barz A., Schrag D., and Basch E. Electronic symptom reporting by cancer patients (2006) Oncology Nursing Society 31st Annual Congress; Boston, MA: May
30. Basch E., Artz D., Dulko D., Scher K., Sabbatini P., Hensley M., et al. Patient self-reporting of toxicity symptoms during chemotherapy (2005) American Society of Clinical Oncology 2005 Annual Meeting; Orlando, FL: May
31. Basch E., Barz A., Kris M., Culkin A., and Schrag D. Online reporting of toxicity symptoms by lung cancer patients during chemotherapy (2005) International Society for Pharmacoeconomics and Outcomes Research 11th Annual International Meeting; Philadelphia, PA: May
32. Goldberg R.M., Sargent D.J., Morton R.F., Mahoney M.R., Krook J.E., and O'Connell M.J. Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program. J Clin Oncol 20 23 (2002) 4591-4596
33. Sargent D.J., Goldberg R.M., Mahoney M.R., Hillman D.W., McKeough T., Hamilton S.F., et al. Rapid reporting and review of an increased incidence of a known adverse event. J Natl Cancer Inst 92 12 (2000) 1011-1013